Prevagen Dietary Supplements
March 16th, 2017
In February 2017, a class-action lawsuit was filed against Quincy Bioscience for allegedly deceptively marketing Prevagen dietary supplements as clinically
Browsing the "prevagen" Tag
Prevagen Supplement
February 13th, 2017
February 2017: Quincy Bioscience moved for an order staying the proceedings in this action pending the resolution of the lawsuit
Prevagen Products
February 9th, 2017
In February 2017, a class-action lawsuit was filed against Quincy Bioscience for allegedly falsely representing that Prevagen supplements improve memory
Prevagen Supplements
January 10th, 2017
A false advertising class-action lawsuit against Quincy Bioscience was dismissed in June 2016. The complaint, which was originally filed in
Prevagen’s Fishy Memory Claims Under Fire by Federal Regulators
January 9th, 2017
Five things you should know about the FTC, New York lawsuit against Prevagen.
Ad Watchdog Calls Out Broadcast Networks for Airing Deceptive Ads
January 19th, 2016
TINA.org Urges Better Screening MADISON, CONN., January 19, 2016 – Consumer advocacy organization, truthinadvertising.org (TINA.org), has put major broadcast networks
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
January 19th, 2016
TINA.org also calls on the BBB to re-evaluate company's A-plus rating.
FTC Complaint Filed Against Maker of Memory Supplement
September 21st, 2015
Ad Watchdog Issues Warning to Consumers MADISON, CONN. September 21, 2015 — With an aging baby-boomer population and an estimated
Prevagen Studies
September 20th, 2015
The Effects of the Calcium Binding Protein Apoaequorin on Memory and Cognitive Functioning in Older Adults Impact of Prevagen on
TINA.org to FTC: Prevagen is Making Unsupported Memory Claims
September 20th, 2015
Investigation finds no competent evidence to support memory improvement claims and FTC files a lawsuit.
Summary of Action
September 20th, 2015
TINA.org investigated the marketing of Prevagen, an over-the-counter supplement aimed at people suffering from memory loss, and determined that Quincy
Status & Updates
September 20th, 2015
January 10, 2017: The BBB changes its A+ rating of Quincy Bioscience to “No Rating.” January 9, 2017: The FTC,
Prevagen Studies
September 20th, 2015
The Effects of the Calcium Binding Protein Apoaequorin on Memory and Cognitive Functioning in Older Adults Impact of Prevagen on
Prevagen Webpages
September 20th, 2015
Prevagen – Homepage Prevagen – About Prevagen – Who We Are Prevagen – Reviews Prevagen – Research Prevagen – See
Prevagen Other
September 20th, 2015
FDA Warning letter 10-16-12 U.S. Patent for Prevagen Racies v Quincy Bioscience – complaint Guevara v Quincy Bioscience – voluntary
Prevagen Videos
September 20th, 2015
Below are links to videos that Quincy Bioscience has used to market Prevagen: Prevagen for Memory and Brain Support Prevagen
